For the quarter ending 2026-03-31, NXGLW has $11,598K in assets. $7,116K in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | - | - | 938 | - |
| Cash | 208 | 317 | - | 725 |
| Restricted cash | 1,914 | 741 | 920 | - |
| Accounts receivable, net | 662 | 673 | 839 | 753 |
| Inventory, net | 2,263 | 2,111 | 2,019 | 1,821 |
| Prepaid expenses and other current assets | 591 | 496 | 886 | 863 |
| Total current assets | 5,638 | 4,338 | 5,602 | 4,162 |
| Goodwill | 1,128 | 1,128 | 1,128 | 1,128 |
| Intangibles, net | 655 | 681 | 712 | 744 |
| Property and equipment, gross | 3,332 | 3,324 | 3,284 | - |
| Less accumulated depreciation and amortization | 1,441 | 1,369 | 1,288 | - |
| Property and equipment, net | 1,891 | 1,955 | 1,996 | 2,070 |
| Operating lease - right of use asset | 1,942 | 2,015 | 2,087 | 1,512 |
| Investment in nexgelrx | 249 | 249 | - | - |
| Other assets | 95 | 95 | 95 | 95 |
| Total assets | 11,598 | 10,461 | 11,620 | 9,711 |
| Accounts payable - related party-Nonrelated Party | 1,202 | 723 | 795 | 826 |
| Warrant liability | - | - | - | 14 |
| Deferred revenue | - | 2 | 180 | 180 |
| Contingent consideration liability | - | - | - | 0 |
| Accounts payable - related party-Related Party | 604 | 566 | 421 | 447 |
| Notes payable, net of current portion | - | 489 | 515 | 539 |
| Accrued expenses and other current liabilities | 428 | 460 | 530 | 534 |
| Current portion of note payable | 100 | 99 | 99 | 99 |
| Partnership accrued advance | 596 | 731 | 920 | - |
| Warrant liability and contingent consideration liability | - | - | 6 | - |
| Current portion of finance lease liability | 65 | 65 | 64 | 62 |
| Current portion of operating lease liability | 319 | 310 | 293 | 234 |
| Total current liabilities | 3,314 | 2,956 | 3,308 | 2,396 |
| Operating lease liabilities, net of current portion | 1,801 | 1,883 | 1,962 | 1,446 |
| Financing lease liability, net of current portion | 226 | 242 | 259 | 275 |
| Convertible notes payable | 1,312 | - | - | - |
| Notes payable, net of current portion | 463 | - | - | - |
| Total liabilities | 7,116 | 5,570 | 6,044 | 4,656 |
| Common stock, par value 0.001 per share, 25,000,000 shares authorized 8,475,693 and 8,143,133 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 8 | 8 | 8 | 8 |
| Additional paid-in capital | 25,909 | 25,447 | 25,204 | 24,036 |
| Accumulated deficit | -21,923 | -20,996 | -20,026 | -19,373 |
| Total nexgel stockholders equity | 3,994 | 4,459 | 5,186 | 4,671 |
| Non-controlling interest in joint venture | 488 | 432 | 390 | 384 |
| Total stockholders equity | 4,482 | 4,891 | 5,576 | 5,055 |
| Total liabilities and stockholders equity | 11,598 | 10,461 | 11,620 | 9,711 |
NEXGEL, INC. (NXGLW)
NEXGEL, INC. (NXGLW)